Series D - Alder Biopharmaceuticals
Investment Firm
Overview
Alder Biopharmaceuticals uses their proprietary technologies to accelerate antibody discovery and development.
Announced Date
Apr 19, 2012
Closed on Date
Apr 19, 2012
Funding Type
Series D
Highlights
Location
United States, North America
Social
Participant Investors
7
Round Details and Background
Alder Biopharmaceuticals raised $38000000 on 2012-04-19 in Series D
Alder Biopharmaceuticals uses their proprietary technologies to accelerate antibody discovery and development.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 01, 2007 |  Series C - Alder Biopharmaceuticals | 2 | - | 40.0M |
| Jul 01, 2005 | Series A - Alder Biopharmaceuticals | 3 | - | 11.0M |
| Jul 01, 2006 | Series B - Alder Biopharmaceuticals | 5 | - | 16.0M |
| Apr 19, 2012 | Series D - Alder Biopharmaceuticals | 7 | - | 38.0M |
Recent Activity
There is no recent news or activity for this profile.